Aberdeen Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99M | Sell |
|
|||||
|
2025
Q1 | $121M | Sell |
|
|||||
|
2024
Q4 | $128M | Sell |
|
|||||
|
2024
Q3 | $187M | Buy |
|
|||||
|
2024
Q2 | $148M | Sell |
|
|||||
|
2024
Q1 | $145M | Buy |
|
|||||
|
2023
Q4 | $131M | Buy |
|
|||||
|
2023
Q3 | $64.9M | Buy |
|
|||||
|
2023
Q2 | $65.6M | Buy |
|
|||||
|
2023
Q1 | $62.6M | Buy |
|
|||||
|
2022
Q4 | $65.9M | Buy |
|
|||||
|
2022
Q3 | $43.9M | Buy |
|
|||||
|
2022
Q2 | $35.3M | Sell |
|
|||||
|
2022
Q1 | $36.9M | Sell |
|
|||||
|
2021
Q4 | $48.8M | Sell |
|
|||||
|
2021
Q3 | $42.4M | Sell |
|
|||||
|
2021
Q2 | $44M | Sell |
|
|||||
|
2021
Q1 | $43.9M | Buy |
|
|||||
|
2020
Q4 | $35.2M | Buy |
|
|||||
|
2020
Q3 | $28.8M | Sell |
|
|||||
|
2020
Q2 | $31.5M | Sell |
|
|||||
|
2020
Q1 | $28M | Buy |
|
|||||
|
2019
Q4 | $36.5M | Sell |
|
|||||
|
2019
Q3 | $56.1M | Sell |
|
|||||
|
2019
Q2 | $76.5M | Sell |
|
|||||
|
2019
Q1 | $81.3M | Sell |
|
|||||
|
2018
Q4 | $164M | Sell |
|
|||||
|
2018
Q3 | $194M | Sell |
|
|||||
|
2018
Q2 | $188M | Sell |
|
|||||
|
2018
Q1 | $181M | Buy |
|
|||||
|
2017
Q4 | $69.1M | Sell |
|
|||||
|
2017
Q3 | $59.2M | Buy |
|